Medical Care
Global Systemic Candidiasis Market Research Report 2024
- Apr 15, 24
- ID: 168723
- Pages: 83
- Figures: 163
- Views: 12
Systemic candidiasis includes a spectrum of yeast infections caused by different species (types) of Candida. It is a serious infection that can affect the blood, heart, brain, eyes, bones, or other parts of the body.
The global Systemic Candidiasis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Systemic Candidiasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Systemic Candidiasis.
Report Scope
The Systemic Candidiasis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Systemic Candidiasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Systemic Candidiasis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis Ag
Sanofi-Aventis
Pfizer, Inc.
Merck And Co., Inc.
Enzon Pharmaceuticals Inc.
Bayer Ag
Astellas Pharma, Inc.
Glaxosmithkline Plc
Abbott
Cipla
Segment by Type
Systemic Oral Azoles
Voriconazole
Liposomal Amphotericin B
Topical Antifungal Agents
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Systemic Candidiasis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Systemic Candidiasis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Systemic Candidiasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Systemic Candidiasis.
Report Scope
The Systemic Candidiasis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Systemic Candidiasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Systemic Candidiasis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis Ag
Sanofi-Aventis
Pfizer, Inc.
Merck And Co., Inc.
Enzon Pharmaceuticals Inc.
Bayer Ag
Astellas Pharma, Inc.
Glaxosmithkline Plc
Abbott
Cipla
Segment by Type
Systemic Oral Azoles
Voriconazole
Liposomal Amphotericin B
Topical Antifungal Agents
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Systemic Candidiasis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Systemic Candidiasis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Systemic Oral Azoles
1.2.3 Voriconazole
1.2.4 Liposomal Amphotericin B
1.2.5 Topical Antifungal Agents
1.2.6 Others
1.3 Market by Application
1.3.1 Global Systemic Candidiasis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Systemic Candidiasis Market Perspective (2019-2030)
2.2 Systemic Candidiasis Growth Trends by Region
2.2.1 Global Systemic Candidiasis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Systemic Candidiasis Historic Market Size by Region (2019-2024)
2.2.3 Systemic Candidiasis Forecasted Market Size by Region (2025-2030)
2.3 Systemic Candidiasis Market Dynamics
2.3.1 Systemic Candidiasis Industry Trends
2.3.2 Systemic Candidiasis Market Drivers
2.3.3 Systemic Candidiasis Market Challenges
2.3.4 Systemic Candidiasis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Systemic Candidiasis Players by Revenue
3.1.1 Global Top Systemic Candidiasis Players by Revenue (2019-2024)
3.1.2 Global Systemic Candidiasis Revenue Market Share by Players (2019-2024)
3.2 Global Systemic Candidiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Systemic Candidiasis Revenue
3.4 Global Systemic Candidiasis Market Concentration Ratio
3.4.1 Global Systemic Candidiasis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Systemic Candidiasis Revenue in 2023
3.5 Systemic Candidiasis Key Players Head office and Area Served
3.6 Key Players Systemic Candidiasis Product Solution and Service
3.7 Date of Enter into Systemic Candidiasis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Systemic Candidiasis Breakdown Data by Type
4.1 Global Systemic Candidiasis Historic Market Size by Type (2019-2024)
4.2 Global Systemic Candidiasis Forecasted Market Size by Type (2025-2030)
5 Systemic Candidiasis Breakdown Data by Application
5.1 Global Systemic Candidiasis Historic Market Size by Application (2019-2024)
5.2 Global Systemic Candidiasis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Systemic Candidiasis Market Size (2019-2030)
6.2 North America Systemic Candidiasis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Systemic Candidiasis Market Size by Country (2019-2024)
6.4 North America Systemic Candidiasis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Systemic Candidiasis Market Size (2019-2030)
7.2 Europe Systemic Candidiasis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Systemic Candidiasis Market Size by Country (2019-2024)
7.4 Europe Systemic Candidiasis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Systemic Candidiasis Market Size (2019-2030)
8.2 Asia-Pacific Systemic Candidiasis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Systemic Candidiasis Market Size by Region (2019-2024)
8.4 Asia-Pacific Systemic Candidiasis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Systemic Candidiasis Market Size (2019-2030)
9.2 Latin America Systemic Candidiasis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Systemic Candidiasis Market Size by Country (2019-2024)
9.4 Latin America Systemic Candidiasis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Systemic Candidiasis Market Size (2019-2030)
10.2 Middle East & Africa Systemic Candidiasis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Systemic Candidiasis Market Size by Country (2019-2024)
10.4 Middle East & Africa Systemic Candidiasis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis Ag
11.1.1 Novartis Ag Company Detail
11.1.2 Novartis Ag Business Overview
11.1.3 Novartis Ag Systemic Candidiasis Introduction
11.1.4 Novartis Ag Revenue in Systemic Candidiasis Business (2019-2024)
11.1.5 Novartis Ag Recent Development
11.2 Sanofi-Aventis
11.2.1 Sanofi-Aventis Company Detail
11.2.2 Sanofi-Aventis Business Overview
11.2.3 Sanofi-Aventis Systemic Candidiasis Introduction
11.2.4 Sanofi-Aventis Revenue in Systemic Candidiasis Business (2019-2024)
11.2.5 Sanofi-Aventis Recent Development
11.3 Pfizer, Inc.
11.3.1 Pfizer, Inc. Company Detail
11.3.2 Pfizer, Inc. Business Overview
11.3.3 Pfizer, Inc. Systemic Candidiasis Introduction
11.3.4 Pfizer, Inc. Revenue in Systemic Candidiasis Business (2019-2024)
11.3.5 Pfizer, Inc. Recent Development
11.4 Merck And Co., Inc.
11.4.1 Merck And Co., Inc. Company Detail
11.4.2 Merck And Co., Inc. Business Overview
11.4.3 Merck And Co., Inc. Systemic Candidiasis Introduction
11.4.4 Merck And Co., Inc. Revenue in Systemic Candidiasis Business (2019-2024)
11.4.5 Merck And Co., Inc. Recent Development
11.5 Enzon Pharmaceuticals Inc.
11.5.1 Enzon Pharmaceuticals Inc. Company Detail
11.5.2 Enzon Pharmaceuticals Inc. Business Overview
11.5.3 Enzon Pharmaceuticals Inc. Systemic Candidiasis Introduction
11.5.4 Enzon Pharmaceuticals Inc. Revenue in Systemic Candidiasis Business (2019-2024)
11.5.5 Enzon Pharmaceuticals Inc. Recent Development
11.6 Bayer Ag
11.6.1 Bayer Ag Company Detail
11.6.2 Bayer Ag Business Overview
11.6.3 Bayer Ag Systemic Candidiasis Introduction
11.6.4 Bayer Ag Revenue in Systemic Candidiasis Business (2019-2024)
11.6.5 Bayer Ag Recent Development
11.7 Astellas Pharma, Inc.
11.7.1 Astellas Pharma, Inc. Company Detail
11.7.2 Astellas Pharma, Inc. Business Overview
11.7.3 Astellas Pharma, Inc. Systemic Candidiasis Introduction
11.7.4 Astellas Pharma, Inc. Revenue in Systemic Candidiasis Business (2019-2024)
11.7.5 Astellas Pharma, Inc. Recent Development
11.8 Glaxosmithkline Plc
11.8.1 Glaxosmithkline Plc Company Detail
11.8.2 Glaxosmithkline Plc Business Overview
11.8.3 Glaxosmithkline Plc Systemic Candidiasis Introduction
11.8.4 Glaxosmithkline Plc Revenue in Systemic Candidiasis Business (2019-2024)
11.8.5 Glaxosmithkline Plc Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Systemic Candidiasis Introduction
11.9.4 Abbott Revenue in Systemic Candidiasis Business (2019-2024)
11.9.5 Abbott Recent Development
11.10 Cipla
11.10.1 Cipla Company Detail
11.10.2 Cipla Business Overview
11.10.3 Cipla Systemic Candidiasis Introduction
11.10.4 Cipla Revenue in Systemic Candidiasis Business (2019-2024)
11.10.5 Cipla Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Systemic Candidiasis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Systemic Oral Azoles
1.2.3 Voriconazole
1.2.4 Liposomal Amphotericin B
1.2.5 Topical Antifungal Agents
1.2.6 Others
1.3 Market by Application
1.3.1 Global Systemic Candidiasis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Systemic Candidiasis Market Perspective (2019-2030)
2.2 Systemic Candidiasis Growth Trends by Region
2.2.1 Global Systemic Candidiasis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Systemic Candidiasis Historic Market Size by Region (2019-2024)
2.2.3 Systemic Candidiasis Forecasted Market Size by Region (2025-2030)
2.3 Systemic Candidiasis Market Dynamics
2.3.1 Systemic Candidiasis Industry Trends
2.3.2 Systemic Candidiasis Market Drivers
2.3.3 Systemic Candidiasis Market Challenges
2.3.4 Systemic Candidiasis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Systemic Candidiasis Players by Revenue
3.1.1 Global Top Systemic Candidiasis Players by Revenue (2019-2024)
3.1.2 Global Systemic Candidiasis Revenue Market Share by Players (2019-2024)
3.2 Global Systemic Candidiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Systemic Candidiasis Revenue
3.4 Global Systemic Candidiasis Market Concentration Ratio
3.4.1 Global Systemic Candidiasis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Systemic Candidiasis Revenue in 2023
3.5 Systemic Candidiasis Key Players Head office and Area Served
3.6 Key Players Systemic Candidiasis Product Solution and Service
3.7 Date of Enter into Systemic Candidiasis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Systemic Candidiasis Breakdown Data by Type
4.1 Global Systemic Candidiasis Historic Market Size by Type (2019-2024)
4.2 Global Systemic Candidiasis Forecasted Market Size by Type (2025-2030)
5 Systemic Candidiasis Breakdown Data by Application
5.1 Global Systemic Candidiasis Historic Market Size by Application (2019-2024)
5.2 Global Systemic Candidiasis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Systemic Candidiasis Market Size (2019-2030)
6.2 North America Systemic Candidiasis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Systemic Candidiasis Market Size by Country (2019-2024)
6.4 North America Systemic Candidiasis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Systemic Candidiasis Market Size (2019-2030)
7.2 Europe Systemic Candidiasis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Systemic Candidiasis Market Size by Country (2019-2024)
7.4 Europe Systemic Candidiasis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Systemic Candidiasis Market Size (2019-2030)
8.2 Asia-Pacific Systemic Candidiasis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Systemic Candidiasis Market Size by Region (2019-2024)
8.4 Asia-Pacific Systemic Candidiasis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Systemic Candidiasis Market Size (2019-2030)
9.2 Latin America Systemic Candidiasis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Systemic Candidiasis Market Size by Country (2019-2024)
9.4 Latin America Systemic Candidiasis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Systemic Candidiasis Market Size (2019-2030)
10.2 Middle East & Africa Systemic Candidiasis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Systemic Candidiasis Market Size by Country (2019-2024)
10.4 Middle East & Africa Systemic Candidiasis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis Ag
11.1.1 Novartis Ag Company Detail
11.1.2 Novartis Ag Business Overview
11.1.3 Novartis Ag Systemic Candidiasis Introduction
11.1.4 Novartis Ag Revenue in Systemic Candidiasis Business (2019-2024)
11.1.5 Novartis Ag Recent Development
11.2 Sanofi-Aventis
11.2.1 Sanofi-Aventis Company Detail
11.2.2 Sanofi-Aventis Business Overview
11.2.3 Sanofi-Aventis Systemic Candidiasis Introduction
11.2.4 Sanofi-Aventis Revenue in Systemic Candidiasis Business (2019-2024)
11.2.5 Sanofi-Aventis Recent Development
11.3 Pfizer, Inc.
11.3.1 Pfizer, Inc. Company Detail
11.3.2 Pfizer, Inc. Business Overview
11.3.3 Pfizer, Inc. Systemic Candidiasis Introduction
11.3.4 Pfizer, Inc. Revenue in Systemic Candidiasis Business (2019-2024)
11.3.5 Pfizer, Inc. Recent Development
11.4 Merck And Co., Inc.
11.4.1 Merck And Co., Inc. Company Detail
11.4.2 Merck And Co., Inc. Business Overview
11.4.3 Merck And Co., Inc. Systemic Candidiasis Introduction
11.4.4 Merck And Co., Inc. Revenue in Systemic Candidiasis Business (2019-2024)
11.4.5 Merck And Co., Inc. Recent Development
11.5 Enzon Pharmaceuticals Inc.
11.5.1 Enzon Pharmaceuticals Inc. Company Detail
11.5.2 Enzon Pharmaceuticals Inc. Business Overview
11.5.3 Enzon Pharmaceuticals Inc. Systemic Candidiasis Introduction
11.5.4 Enzon Pharmaceuticals Inc. Revenue in Systemic Candidiasis Business (2019-2024)
11.5.5 Enzon Pharmaceuticals Inc. Recent Development
11.6 Bayer Ag
11.6.1 Bayer Ag Company Detail
11.6.2 Bayer Ag Business Overview
11.6.3 Bayer Ag Systemic Candidiasis Introduction
11.6.4 Bayer Ag Revenue in Systemic Candidiasis Business (2019-2024)
11.6.5 Bayer Ag Recent Development
11.7 Astellas Pharma, Inc.
11.7.1 Astellas Pharma, Inc. Company Detail
11.7.2 Astellas Pharma, Inc. Business Overview
11.7.3 Astellas Pharma, Inc. Systemic Candidiasis Introduction
11.7.4 Astellas Pharma, Inc. Revenue in Systemic Candidiasis Business (2019-2024)
11.7.5 Astellas Pharma, Inc. Recent Development
11.8 Glaxosmithkline Plc
11.8.1 Glaxosmithkline Plc Company Detail
11.8.2 Glaxosmithkline Plc Business Overview
11.8.3 Glaxosmithkline Plc Systemic Candidiasis Introduction
11.8.4 Glaxosmithkline Plc Revenue in Systemic Candidiasis Business (2019-2024)
11.8.5 Glaxosmithkline Plc Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Systemic Candidiasis Introduction
11.9.4 Abbott Revenue in Systemic Candidiasis Business (2019-2024)
11.9.5 Abbott Recent Development
11.10 Cipla
11.10.1 Cipla Company Detail
11.10.2 Cipla Business Overview
11.10.3 Cipla Systemic Candidiasis Introduction
11.10.4 Cipla Revenue in Systemic Candidiasis Business (2019-2024)
11.10.5 Cipla Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Systemic Candidiasis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Systemic Oral Azoles
Table 3. Key Players of Voriconazole
Table 4. Key Players of Liposomal Amphotericin B
Table 5. Key Players of Topical Antifungal Agents
Table 6. Key Players of Others
Table 7. Global Systemic Candidiasis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Systemic Candidiasis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Systemic Candidiasis Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Systemic Candidiasis Market Share by Region (2019-2024)
Table 11. Global Systemic Candidiasis Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Systemic Candidiasis Market Share by Region (2025-2030)
Table 13. Systemic Candidiasis Market Trends
Table 14. Systemic Candidiasis Market Drivers
Table 15. Systemic Candidiasis Market Challenges
Table 16. Systemic Candidiasis Market Restraints
Table 17. Global Systemic Candidiasis Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Systemic Candidiasis Market Share by Players (2019-2024)
Table 19. Global Top Systemic Candidiasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Candidiasis as of 2023)
Table 20. Ranking of Global Top Systemic Candidiasis Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Systemic Candidiasis Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Systemic Candidiasis Product Solution and Service
Table 24. Date of Enter into Systemic Candidiasis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Systemic Candidiasis Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Systemic Candidiasis Revenue Market Share by Type (2019-2024)
Table 28. Global Systemic Candidiasis Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Systemic Candidiasis Revenue Market Share by Type (2025-2030)
Table 30. Global Systemic Candidiasis Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Systemic Candidiasis Revenue Market Share by Application (2019-2024)
Table 32. Global Systemic Candidiasis Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Systemic Candidiasis Revenue Market Share by Application (2025-2030)
Table 34. North America Systemic Candidiasis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Systemic Candidiasis Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Systemic Candidiasis Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Systemic Candidiasis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Systemic Candidiasis Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Systemic Candidiasis Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Systemic Candidiasis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Systemic Candidiasis Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Systemic Candidiasis Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Systemic Candidiasis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Systemic Candidiasis Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Systemic Candidiasis Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Systemic Candidiasis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Systemic Candidiasis Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Systemic Candidiasis Market Size by Country (2025-2030) & (US$ Million)
Table 49. Novartis Ag Company Detail
Table 50. Novartis Ag Business Overview
Table 51. Novartis Ag Systemic Candidiasis Product
Table 52. Novartis Ag Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 53. Novartis Ag Recent Development
Table 54. Sanofi-Aventis Company Detail
Table 55. Sanofi-Aventis Business Overview
Table 56. Sanofi-Aventis Systemic Candidiasis Product
Table 57. Sanofi-Aventis Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 58. Sanofi-Aventis Recent Development
Table 59. Pfizer, Inc. Company Detail
Table 60. Pfizer, Inc. Business Overview
Table 61. Pfizer, Inc. Systemic Candidiasis Product
Table 62. Pfizer, Inc. Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 63. Pfizer, Inc. Recent Development
Table 64. Merck And Co., Inc. Company Detail
Table 65. Merck And Co., Inc. Business Overview
Table 66. Merck And Co., Inc. Systemic Candidiasis Product
Table 67. Merck And Co., Inc. Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 68. Merck And Co., Inc. Recent Development
Table 69. Enzon Pharmaceuticals Inc. Company Detail
Table 70. Enzon Pharmaceuticals Inc. Business Overview
Table 71. Enzon Pharmaceuticals Inc. Systemic Candidiasis Product
Table 72. Enzon Pharmaceuticals Inc. Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 73. Enzon Pharmaceuticals Inc. Recent Development
Table 74. Bayer Ag Company Detail
Table 75. Bayer Ag Business Overview
Table 76. Bayer Ag Systemic Candidiasis Product
Table 77. Bayer Ag Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 78. Bayer Ag Recent Development
Table 79. Astellas Pharma, Inc. Company Detail
Table 80. Astellas Pharma, Inc. Business Overview
Table 81. Astellas Pharma, Inc. Systemic Candidiasis Product
Table 82. Astellas Pharma, Inc. Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 83. Astellas Pharma, Inc. Recent Development
Table 84. Glaxosmithkline Plc Company Detail
Table 85. Glaxosmithkline Plc Business Overview
Table 86. Glaxosmithkline Plc Systemic Candidiasis Product
Table 87. Glaxosmithkline Plc Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 88. Glaxosmithkline Plc Recent Development
Table 89. Abbott Company Detail
Table 90. Abbott Business Overview
Table 91. Abbott Systemic Candidiasis Product
Table 92. Abbott Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 93. Abbott Recent Development
Table 94. Cipla Company Detail
Table 95. Cipla Business Overview
Table 96. Cipla Systemic Candidiasis Product
Table 97. Cipla Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 98. Cipla Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Systemic Candidiasis Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Systemic Candidiasis Market Share by Type: 2023 VS 2030
Figure 3. Systemic Oral Azoles Features
Figure 4. Voriconazole Features
Figure 5. Liposomal Amphotericin B Features
Figure 6. Topical Antifungal Agents Features
Figure 7. Others Features
Figure 8. Global Systemic Candidiasis Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Systemic Candidiasis Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Systemic Candidiasis Report Years Considered
Figure 14. Global Systemic Candidiasis Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Systemic Candidiasis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Systemic Candidiasis Market Share by Region: 2023 VS 2030
Figure 17. Global Systemic Candidiasis Market Share by Players in 2023
Figure 18. Global Top Systemic Candidiasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Candidiasis as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Systemic Candidiasis Revenue in 2023
Figure 20. North America Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Systemic Candidiasis Market Share by Country (2019-2030)
Figure 22. United States Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Systemic Candidiasis Market Share by Country (2019-2030)
Figure 26. Germany Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Systemic Candidiasis Market Share by Region (2019-2030)
Figure 34. China Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Systemic Candidiasis Market Share by Country (2019-2030)
Figure 42. Mexico Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Systemic Candidiasis Market Share by Country (2019-2030)
Figure 46. Turkey Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Novartis Ag Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 49. Sanofi-Aventis Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 50. Pfizer, Inc. Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 51. Merck And Co., Inc. Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 52. Enzon Pharmaceuticals Inc. Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 53. Bayer Ag Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 54. Astellas Pharma, Inc. Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 55. Glaxosmithkline Plc Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 56. Abbott Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 57. Cipla Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Systemic Candidiasis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Systemic Oral Azoles
Table 3. Key Players of Voriconazole
Table 4. Key Players of Liposomal Amphotericin B
Table 5. Key Players of Topical Antifungal Agents
Table 6. Key Players of Others
Table 7. Global Systemic Candidiasis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Systemic Candidiasis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Systemic Candidiasis Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Systemic Candidiasis Market Share by Region (2019-2024)
Table 11. Global Systemic Candidiasis Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Systemic Candidiasis Market Share by Region (2025-2030)
Table 13. Systemic Candidiasis Market Trends
Table 14. Systemic Candidiasis Market Drivers
Table 15. Systemic Candidiasis Market Challenges
Table 16. Systemic Candidiasis Market Restraints
Table 17. Global Systemic Candidiasis Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Systemic Candidiasis Market Share by Players (2019-2024)
Table 19. Global Top Systemic Candidiasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Candidiasis as of 2023)
Table 20. Ranking of Global Top Systemic Candidiasis Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Systemic Candidiasis Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Systemic Candidiasis Product Solution and Service
Table 24. Date of Enter into Systemic Candidiasis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Systemic Candidiasis Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Systemic Candidiasis Revenue Market Share by Type (2019-2024)
Table 28. Global Systemic Candidiasis Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Systemic Candidiasis Revenue Market Share by Type (2025-2030)
Table 30. Global Systemic Candidiasis Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Systemic Candidiasis Revenue Market Share by Application (2019-2024)
Table 32. Global Systemic Candidiasis Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Systemic Candidiasis Revenue Market Share by Application (2025-2030)
Table 34. North America Systemic Candidiasis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Systemic Candidiasis Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Systemic Candidiasis Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Systemic Candidiasis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Systemic Candidiasis Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Systemic Candidiasis Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Systemic Candidiasis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Systemic Candidiasis Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Systemic Candidiasis Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Systemic Candidiasis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Systemic Candidiasis Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Systemic Candidiasis Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Systemic Candidiasis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Systemic Candidiasis Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Systemic Candidiasis Market Size by Country (2025-2030) & (US$ Million)
Table 49. Novartis Ag Company Detail
Table 50. Novartis Ag Business Overview
Table 51. Novartis Ag Systemic Candidiasis Product
Table 52. Novartis Ag Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 53. Novartis Ag Recent Development
Table 54. Sanofi-Aventis Company Detail
Table 55. Sanofi-Aventis Business Overview
Table 56. Sanofi-Aventis Systemic Candidiasis Product
Table 57. Sanofi-Aventis Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 58. Sanofi-Aventis Recent Development
Table 59. Pfizer, Inc. Company Detail
Table 60. Pfizer, Inc. Business Overview
Table 61. Pfizer, Inc. Systemic Candidiasis Product
Table 62. Pfizer, Inc. Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 63. Pfizer, Inc. Recent Development
Table 64. Merck And Co., Inc. Company Detail
Table 65. Merck And Co., Inc. Business Overview
Table 66. Merck And Co., Inc. Systemic Candidiasis Product
Table 67. Merck And Co., Inc. Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 68. Merck And Co., Inc. Recent Development
Table 69. Enzon Pharmaceuticals Inc. Company Detail
Table 70. Enzon Pharmaceuticals Inc. Business Overview
Table 71. Enzon Pharmaceuticals Inc. Systemic Candidiasis Product
Table 72. Enzon Pharmaceuticals Inc. Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 73. Enzon Pharmaceuticals Inc. Recent Development
Table 74. Bayer Ag Company Detail
Table 75. Bayer Ag Business Overview
Table 76. Bayer Ag Systemic Candidiasis Product
Table 77. Bayer Ag Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 78. Bayer Ag Recent Development
Table 79. Astellas Pharma, Inc. Company Detail
Table 80. Astellas Pharma, Inc. Business Overview
Table 81. Astellas Pharma, Inc. Systemic Candidiasis Product
Table 82. Astellas Pharma, Inc. Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 83. Astellas Pharma, Inc. Recent Development
Table 84. Glaxosmithkline Plc Company Detail
Table 85. Glaxosmithkline Plc Business Overview
Table 86. Glaxosmithkline Plc Systemic Candidiasis Product
Table 87. Glaxosmithkline Plc Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 88. Glaxosmithkline Plc Recent Development
Table 89. Abbott Company Detail
Table 90. Abbott Business Overview
Table 91. Abbott Systemic Candidiasis Product
Table 92. Abbott Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 93. Abbott Recent Development
Table 94. Cipla Company Detail
Table 95. Cipla Business Overview
Table 96. Cipla Systemic Candidiasis Product
Table 97. Cipla Revenue in Systemic Candidiasis Business (2019-2024) & (US$ Million)
Table 98. Cipla Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Systemic Candidiasis Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Systemic Candidiasis Market Share by Type: 2023 VS 2030
Figure 3. Systemic Oral Azoles Features
Figure 4. Voriconazole Features
Figure 5. Liposomal Amphotericin B Features
Figure 6. Topical Antifungal Agents Features
Figure 7. Others Features
Figure 8. Global Systemic Candidiasis Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Systemic Candidiasis Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Systemic Candidiasis Report Years Considered
Figure 14. Global Systemic Candidiasis Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Systemic Candidiasis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Systemic Candidiasis Market Share by Region: 2023 VS 2030
Figure 17. Global Systemic Candidiasis Market Share by Players in 2023
Figure 18. Global Top Systemic Candidiasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Candidiasis as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Systemic Candidiasis Revenue in 2023
Figure 20. North America Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Systemic Candidiasis Market Share by Country (2019-2030)
Figure 22. United States Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Systemic Candidiasis Market Share by Country (2019-2030)
Figure 26. Germany Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Systemic Candidiasis Market Share by Region (2019-2030)
Figure 34. China Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Systemic Candidiasis Market Share by Country (2019-2030)
Figure 42. Mexico Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Systemic Candidiasis Market Share by Country (2019-2030)
Figure 46. Turkey Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Systemic Candidiasis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Novartis Ag Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 49. Sanofi-Aventis Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 50. Pfizer, Inc. Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 51. Merck And Co., Inc. Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 52. Enzon Pharmaceuticals Inc. Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 53. Bayer Ag Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 54. Astellas Pharma, Inc. Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 55. Glaxosmithkline Plc Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 56. Abbott Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 57. Cipla Revenue Growth Rate in Systemic Candidiasis Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232